Collaboration Agreements in the Pharmaceuticals Industry

236 Contracts & Agreements

Browse by Company

ACELRX PHARMACEUTICALS INC (3 contracts)
Acer Therapeutics Inc. (2)
ACHILLION PHARMACEUTICALS INC (1)
Aclaris Therapeutics, Inc. (3)
ACURA PHARMACEUTICALS, INC (1)
AERIE PHARMACEUTICALS INC (2)
ALDER BIOPHARMACEUTICALS INC (2)
Alexza Pharmaceuticals Inc. (5)
ALGORX PHARMACEUTICALS INC (1)
ALIMERA SCIENCES INC (2)
Altus Pharmaceuticals Inc. (1)
Amag Pharmaceuticals (1)
AMYLIN PHARMACEUTICALS INC (1)
Anacor Pharmaceuticals, Inc. (2)
ANI Pharma Inc (1)
ARADIGM CORP (1)
Aralez Pharmaceuticals Inc. (1)
ARIAD PHARMACEUTICALS INC (2)
ARVINAS, INC. (7)
ATAI Life Sciences B.V. (1)
AUXILIUM PHARMACEUTICALS INC (2)
AVALON PHARMACEUTICALS INC (6)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
BioNumerik Pharmaceuticals, Inc. (5)
Bristol-Myers Squibb (1)
CADENCE PHARMACEUTICALS INC (1)
Cancer Prevention Pharmaceuticals, Inc. (1)
Cannabics Pharmaceuticals Inc. (2)
CASSAVA SCIENCES INC (3)
Citius Pharmaceuticals, Inc. (2)
Clearside Biomedical, Inc. (3)
Cocrystal Pharma, Inc. (2)
Context Therapeutics Inc. (2)
Cronos Group Inc. (2)
CUBIST PHARMACEUTICALS INC (1)
CymaBay Therapeutics, Inc. (1)
DiCE MOLECULES HOLDINGS, LLC (1)
Egalet Corp (1)
Elixir Pharmaceuticals, Inc. (1)
Endo Pharmaceuticals Solutions Inc. (1)
EPIX Pharmaceuticals, Inc. (3)
Evofem Biosciences, Inc. (1)
EyePoint Pharmaceuticals, Inc. (2)
EYETECH PHARMACEUTICALS INC (1)
Fulcrum Therapeutics, Inc. (3)
GridIron BioNutrients, Inc. (2)
Horizon Pharma plc (2)
IDENIX PHARMACEUTICALS INC (1)
Ikena Oncology, Inc. (1)
IMAGING3 INC (1)
Innoviva, Inc. (4)
Intra-Cellular Therapies, Inc. (2)
Jaguar Health, Inc. (1)
Jazz Pharmaceuticals plc (1)
Journey Medical Corp (1)
KEMPHARM, INC (3)
KING PHARMACEUTICALS INC (1)
KOS PHARMACEUTICALS INC (1)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (2)
Liquidia Technologies Inc (1)
Lyra Therapeutics, Inc. (2)
MAP Pharmaceuticals, Inc. (2)
MARINUS PHARMACEUTICALS INC (3)
MAXIM PHARMACEUTICALS INC (1)
MEMORY PHARMACEUTICALS CORP (5)
Menlo Therapeutics Inc. (2)
Milestone Pharmaceuticals Inc. (1)
MIRA PHARMACEUTICALS, INC. (1)
MyoKardia Inc (2)
NEKTAR THERAPEUTICS (4)
Neuralstem, Inc. (2)
NEW RIVER PHARMACEUTICALS INC (1)
NGM BIOPHARMACEUTICALS INC (2)
NovaBay Pharmaceuticals, Inc. (2)
Novan, Inc. (1)
OCULAR THERAPEUTIX, INC (1)
OncoMed Pharmaceuticals Inc (13)
Onconova Therapeutics, Inc. (1)
ONYX PHARMACEUTICALS INC (5)
OPTIMER PHARMACEUTICALS INC (3)
OSI PHARMACEUTICALS INC (1)
Pacira Pharmaceuticals, Inc. (1)
Panacea Acquisition Corp (2)
Paratek Pharmaceuticals, Inc. (1)
PaxMedica, Inc. (1)
PENWEST PHARMACEUTICALS CO (1)
Pivot Pharmaceuticals Inc. (1)
PLIANT THERAPEUTICS, INC. (1)
Provention Bio, Inc. (1)
Pulmatrix, Inc. (1)
QUARK PHARMACEUTICALS INC (4)
Ra Pharmaceuticals, Inc. (1)
RADIENT PHARMACEUTICALS Corp (1)
Rani Therapeutics Holdings, Inc. (1)
RespireRx Pharmaceuticals Inc. (1)
resTORbio, Inc. (4)
Revance Therapeutics, Inc. (2)
Rib-X Pharmaceuticals, Inc. (2)
Roivant Sciences Ltd. (4)
SAMARITAN PHARMACEUTICALS INC (1)
SCYNEXIS INC (1)
Sonoma Pharmaceuticals, Inc. (1)
Sucampo Pharmaceuticals, Inc. (1)
Target Group Inc. (1)
TAURIGA SCIENCES, INC. (3)
The Medicines Company (1)
Theravance Biopharma, Inc. (2)
Urovant Sciences Ltd. (3)
Valera Pharmaceuticals Inc (1)
Verona Pharma plc (1)
Verrica Pharmaceuticals Inc. (2)
Virpax Pharmaceuticals, Inc. (7)
Vitae Pharmaceuticals, Inc (7)
Wave Life Sciences Ltd. (2)
Zoetis (2)
ZOGENIX, INC. (1)

Recent Contracts

First Amendment to Collaboration and License Agreement, dated as of May 14, 2024, by and between the Registrant and Torii Pharmaceuticals Co., Ltd (Verrica Pharmaceuticals Inc., Filed With SEC on August 14, 2024)
Amendment to Research Collaboration and License Agreement with Giiant Pharma, Inc. dated August 2, 2024 (Neuralstem, Inc., Filed With SEC on August 12, 2024)
Collaboration Agreement between Rani Therapeutics, LLC and ProGen Co., Ltd. dated June 17, 2024 (Rani Therapeutics Holdings, Inc., Filed With SEC on August 6, 2024)
Amendment to Collaboration and License Agreement between Innovent Biologics (Suzhou) Co. Ltd. and AnHeart Therapeutics Inc, dated November 30, 2022 (Panacea Acquisition Corp, Filed With SEC on June 20, 2024)
Collaboration and License Agreement between Innovent Biologics (Suzhou) Co. Ltd. and AnHeart Therapeutics Inc, dated May 31, 2021 (Panacea Acquisition Corp, Filed With SEC on June 20, 2024)
Research Collaboration Agreement, dated as of June 7, 2023, by and between the Company and PoloMar Health (PaxMedica, Inc., Filed With SEC on March 11, 2024)
Form of Research Collaboration and License Agreement with Giiant Pharma (Neuralstem, Inc., Filed With SEC on September 8, 2023)
First Amendment to Collaboration and License Agreement, effective as of April 20, 2023, by and between the Registrant and MyoKardia, Inc., a wholly-owned subsidiary of Bristol... (Fulcrum Therapeutics, Inc., Filed With SEC on August 3, 2023)
Master Collaboration Agreement, dated November 1, 2021, between MIRA Pharmaceuticals, Inc. and The Johns Hopkins University (MIRA PHARMACEUTICALS, INC., Filed With SEC on July 14, 2023)
Collaboration and License Agreement, dated January 6, 2023, between CymaBay Therapeutics, Inc. and Kaken Pharmaceutical Co., Ltd (CymaBay Therapeutics, Inc., Filed With SEC on March 23, 2023)
Collaboration and Supply Agreement, dated November 16, 2022, between Marinus Pharmaceuticals, Inc. and Tenacia Biotechnology (Shanghai) Co., Ltd (MARINUS PHARMACEUTICALS INC, Filed With SEC on March 9, 2023)
Amendment No. 3 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc (formerly Arvinas, Inc.), dated December 21, 2022 (ARVINAS, INC., Filed With SEC on February 23, 2023)
License and Collaboration Agreement dated as of November 21, 2022 (Roivant Sciences Ltd., Filed With SEC on February 13, 2023)
License and Collaboration Agreement, dated October 18, 2022, between Jazz Pharmaceuticals Ireland Limited and Zymeworks BC Inc (Jazz Pharmaceuticals plc, Filed With SEC on December 5, 2022)
First Amendment to License and Collaboration Agreement, dated September 26, 2022, between Registrant and LianBio Inflammatory Limited and LianBio (Lyra Therapeutics, Inc., Filed With SEC on November 8, 2022)
Clinical Trial Collaboration and Supply Agreement, dated August 1, 2022, by and between Context Therapeutics Inc. and Berlin-Chemie AG - Menarini Group (Context Therapeutics Inc., Filed With SEC on August 11, 2022)
Third Amendment to Collaboration Agreement, dated July 13, 2022, by and among Innoviva, Inc., Glaxo Group Limited, and Theravance Respiratory Company, LLC (Innoviva, Inc., Filed With SEC on July 13, 2022)
Amendment No. 1 to License and Collaboration Agreement, dated as of June 10, 2022, by and between Pfizer Inc. and Priovant, Inc (Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
License and Collaboration Agreement, dated as of September 13, 2021, by and between Pfizer Inc. and Priovant, Inc (Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
Amended and Restated Promotion and Collaboration Agreement, effective as of January 1, 2022, by and between MC2 Therapeutics Limited and EPI Health, LLC (Novan, Inc., Filed With SEC on May 16, 2022)
First Amendment to Collaboration and License Agreement by and between Wave Life Sciences USA, Inc., Wave Life Sciences UK Limited and Takeda Pharmaceutical Company Limited, dated... (Wave Life Sciences Ltd., Filed With SEC on May 12, 2022)
Amendment No. 2 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc. (formerly Arvinas, Inc.), dated January 14, 2022 (ARVINAS, INC., Filed With SEC on May 5, 2022)
Amended and Restated Collaboration and License Agreement between Nanomerics Ltd. and Virpax Pharmaceuticals, Inc., dated as of March 9, 2022 (Virpax Pharmaceuticals, Inc., Filed With SEC on March 31, 2022)
Certain information has been excluded from this agreement (indicated by [***]) because such information is both not material and the type that the registrant treats as private or... (ANI Pharma Inc, Filed With SEC on March 15, 2022)
Second Amendment to Collaboration and License Agreement by and between Wave Life Sciences USA, Inc., Wave Life Sciences UK Limited and Takeda Pharmaceutical Company Limited, dated... (Wave Life Sciences Ltd., Filed With SEC on March 3, 2022)
Amendment No. 2 to Strategic Collaboration Agreement dated as of January 12, 2022, by and between Bristol-M (NEKTAR THERAPEUTICS, Filed With SEC on March 1, 2022)
Collaboration and License Agreement, dated as of December 6, 2021, by and between Aerie Pharmaceuticals Ireland, Ltd. and Santen SA (AERIE PHARMACEUTICALS INC, Filed With SEC on February 25, 2022)
Collaboration Agreement, dated as of July 30, 2021, by and between Marinus Pharmaceuticals, Inc. and Orion Corporation (MARINUS PHARMACEUTICALS INC, Filed With SEC on November 9, 2021)
License, Collaboration, and Assignment Agreement for DFD-29, entered into by and between Journey Medical Corporation and Dr. Reddys Laboratories Ltd., dated as of June 29, 2021 (Journey Medical Corp, Filed With SEC on October 22, 2021)
Collaboration Agreement (IMAGING3 INC, Filed With SEC on October 15, 2021)
Amended and Restated License and Collaboration Agreement, by and between the Registrant and Aventis Inc., dated as of December 17, 2015, as amended and restated as of August 16,... (DiCE MOLECULES HOLDINGS, LLC, Filed With SEC on August 25, 2021)
Amendment No. 1 to Collaboration and License Agreement, effective as of April 8, 2021, by and between the Company and Commave Therapeutics SA (KEMPHARM, INC, Filed With SEC on August 13, 2021)
License and Collaboration Agreement by and among the Company and Ji Xing Pharmaceuticals, Limited, dated May 15, 2021 (Milestone Pharmaceuticals Inc., Filed With SEC on August 11, 2021)
Amendment to the Collaboration and License Agreement dated April 11, 2019, as amended, between Nanomerics Ltd. and Virpax Pharmaceuticals Inc., dated May 5, 2021 (Virpax Pharmaceuticals, Inc., Filed With SEC on August 10, 2021)
Amendment to the Collaboration and License Agreement dated April 11, 2019, as amended, between Nanomerics Ltd. and Virpax Pharmaceuticals, Inc., dated April 6, 2021 (Virpax Pharmaceuticals, Inc., Filed With SEC on August 10, 2021)
License and Collaboration Agreement dated May 31, 2021, by and between the Registrant and LianBio Inflammatory Limited and LianBio (Lyra Therapeutics, Inc., Filed With SEC on August 9, 2021)
Collaboration and License Agreement, effective as of June 9, 2021, by and between Verona Pharma plc, Nuance Pharma Limited and Nuance (Shanghai) Pharma Co Ltd (Verona Pharma plc, Filed With SEC on August 5, 2021)
Exclusive Collaboration and License Agreement by and between the Company and Lian Respiratory Limited, dated May 14, 2021 (Landos Biopharma, Inc., Filed With SEC on July 29, 2021)
Collaboration Agreement, dated July 21, 2021, by and between Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc. and Pfizer, Inc (ARVINAS, INC., Filed With SEC on July 22, 2021)
Amended and Restated Collaboration and License Agreement, dated as of June 3, 2021, by and between Ginkgo Bioworks, Inc. and Cronos Group Inc (Cronos Group Inc., Filed With SEC on June 4, 2021)